BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11030037)

  • 1. Interaction potential of selective serotonin-reuptake inhibitors.
    DeVane CL
    Am J Health Syst Pharm; 2000 Oct; 57(19):1802-3. PubMed ID: 11030037
    [No Abstract]   [Full Text] [Related]  

  • 2. [Medical interactions with antidepressives. Benefits of the specific serotonin reuptake inhibitor citalopram].
    Eckert A; Reiff J; Müller WE
    Med Monatsschr Pharm; 1998 May; 21(5):138-50. PubMed ID: 9617102
    [No Abstract]   [Full Text] [Related]  

  • 3. Citalopram for depression.
    Med Lett Drugs Ther; 1998 Dec; 40(1041):113-4. PubMed ID: 9854566
    [No Abstract]   [Full Text] [Related]  

  • 4. Citalopram versus other selective serotonin-reuptake inhibitors.
    Thomas KV; Holimon TD
    Am J Health Syst Pharm; 1999 Nov; 56(21):2242-4. PubMed ID: 10565706
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyromania associated with escitalopram in a child.
    Ceylan MF; Durukan I; Türkbay T; Akca OF; Kara K
    J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):381-2. PubMed ID: 21823913
    [No Abstract]   [Full Text] [Related]  

  • 6. Citalopram in the treatment of depression and other potential uses in psychiatry.
    Tan JY; Levin GM
    Pharmacotherapy; 1999 Jun; 19(6):675-89. PubMed ID: 10391413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of an interaction between sumatriptan and selective serotonin reuptake inhibitors.
    Leung M; Ong M
    Headache; 1995 Sep; 35(8):488-9. PubMed ID: 7591744
    [No Abstract]   [Full Text] [Related]  

  • 8. Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.
    Ji Y; Schaid DJ; Desta Z; Kubo M; Batzler AJ; Snyder K; Mushiroda T; Kamatani N; Ogburn E; Hall-Flavin D; Flockhart D; Nakamura Y; Mrazek DA; Weinshilboum RM
    Br J Clin Pharmacol; 2014 Aug; 78(2):373-83. PubMed ID: 24528284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citalopram in the treatment of depression.
    Parker NG; Brown CS
    Ann Pharmacother; 2000 Jun; 34(6):761-71. PubMed ID: 10860138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter--a review of current understanding of its mechanism of action.
    Zhong H; Haddjeri N; Sánchez C
    Psychopharmacology (Berl); 2012 Jan; 219(1):1-13. PubMed ID: 21901317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excretion of citalopram in breast milk.
    Spigset O; Carieborg L; Ohman R; Norström A
    Br J Clin Pharmacol; 1997 Sep; 44(3):295-8. PubMed ID: 9296327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Too much hypothalamic serotonin transporter is bad for your mood.
    Gurwitz D
    Trends Mol Med; 2001 Jan; 7(1):8. PubMed ID: 11427992
    [No Abstract]   [Full Text] [Related]  

  • 13. Citalopram plus reboxetine in treatment-resistant depression.
    Devarajan S; Dursun SM
    Can J Psychiatry; 2000 Jun; 45(5):489-90. PubMed ID: 10900531
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
    Preskorn SH
    Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitors for late-life depression: a comparative review.
    Solai LK; Mulsant BH; Pollock BG
    Drugs Aging; 2001; 18(5):355-68. PubMed ID: 11392444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citalopram: a comprehensive review.
    Pollock BG
    Expert Opin Pharmacother; 2001 Apr; 2(4):681-98. PubMed ID: 11336616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update.
    Hemeryck A; Belpaire FM
    Curr Drug Metab; 2002 Feb; 3(1):13-37. PubMed ID: 11876575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes.
    Berle JØ; Steen VM; Aamo TO; Breilid H; Zahlsen K; Spigset O
    J Clin Psychiatry; 2004 Sep; 65(9):1228-34. PubMed ID: 15367050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitors and adjuvant tamoxifen therapy: risk of breast cancer recurrence and mortality.
    Cronin-Fenton D; Lash TL; Sørensen HT
    Future Oncol; 2010 Jun; 6(6):877-80. PubMed ID: 20528223
    [No Abstract]   [Full Text] [Related]  

  • 20. Citalopram and quality of life in lung transplant recipients.
    Silvertooth EJ; Doraiswamy PM; Clary GL; Babyak MA; Wilkerson N; Hellegars C; Palmer SM
    Psychosomatics; 2004; 45(3):271-2. PubMed ID: 15123855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.